MEPs take tough stance on EU pandemic response
This article was originally published in Scrip
A European Parliament committee has strongly criticised the EU's handling of the 2009 flu pandemic, saying it was "disproportionate", unnecessarily costly and fraught with conflicts of interest, and that the European institutions were too closely tied to the World Health Organization to be able to respond appropriately to the unfolding crisis.
You may also be interested in...
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.
With product shortages made worse by the pandemic, companies in the UK are being asked to use a new system for notifying potential supply disruptions and any plans to discontinue specific medicines.
Two new projects have begun, one on standardizing the assessment of immune responses in individuals vaccinated in clinical trials, the other to improve understanding of potential immunity in patients who have been infected with SARS-CoV-2.